Acceleron Pharma (XLRN) PT Raised to $63 at Citi
Tweet
Share
E-mailGet Alerts XLRN Hot Sheet
Price: $178.75 --0%
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 6 | New: 11
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 6 | New: 11
Join SI Premium – FREE
Citi raised its price target on Acceleron Pharma (NASDAQ: XLRN) to $63.00 (from $44.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $143 at Bernstein SocGen Group
- NagaCorp Ltd (3918:HK) (NGCRF) PT Lowered to HK$6 at Goldman Sachs
- Barrick Gold (ABX:CN) (B) PT Raised to Cdn$73 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
